DR. DAVID QUINN YOUNGBLOOD
Prescription History 1982977674
Pharmacist in Weiser, ID
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. DAVID QUINN YOUNGBLOOD, an active Pharmacist specialist practicing in Weiser, ID. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 239 documented patient claims. Among these therapy options, the most frequently utilized medication is Shingrix, which accounts for 119 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other ID PrescribersVs. ID Avg |
|---|---|---|---|
| ShingrixVaricella-Zoster Ge/As01b/Pf | 119 | $212.10 | ▲ More than typical |
In 2023, this provider wrote 119 Medicare prescriptions for Shingrix, about 3.6 times the volume of the typical Idaho prescriber of this medication (33). Medicare paid an average of $212.10 per fill, versus $193.33 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average ID prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 119 30-Day Fills standardized to 30-day supplies 119 Days of Medication total across all patients in 2023 | |||
| ArexvyRsvpref3 Antigen/As01e/Pf | 74 | $307.61 | – No State Data |
In 2023, this provider wrote 74 Medicare prescriptions for Arexvy. Medicare paid an average of $307.61 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $307.61 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 74 30-Day Fills standardized to 30-day supplies 74 Days of Medication total across all patients in 2023 | |||
| Naloxone Hcl | 33 | $86.27▼ below ID avg | ≈ Typical |
About Naloxone Hcl: This medication is used for the emergency treatment of known or suspected opioid overdose. Show more ▾ Serious opioid overdose symptoms may include unusual sleepiness, unusual difficulty waking up, or breathing problems (ranging from slow/shallow breathing to no breathing). Other symptoms of overdose may include very small pinpoint pupils, slow heartbeat, or low blood pressure. If someone has serious overdose symptoms but you are not sure if the symptoms are due to overdose, give this medication right away anyway, since lasting slow/shallow breathing may cause permanent damage to the brain or death. This medication belongs to a class of drugs known as opioid antagonists. It works by blocking the effects of the opioid in the brain. This medication may not work as well to block the effects of certain types of opioids (mixed agonist/antagonists such as buprenorphine, pentazocine). With these types of opioids, blocking may be incomplete or you may need a higher dose of naloxone. The effects of naloxone will not last as long as the effects of the opioid. Since treatment with this medication is not long lasting, be sure to get medical help right away after giving the first dose of naloxone. Treatment of opioid overdose should also include breathing treatment (such as oxygen given through tubes in the nose, mechanical ventilation, artificial respiration). A specific opiate antagonist that has no agonist activity. It is a competitive antagonist at mu, delta, and kappa opioid receptors. In 2023, this provider wrote 33 Medicare prescriptions for Naloxone Hcl, about the same volume as the typical Idaho prescriber of this medication (32). Medicare paid an average of $86.27 per fill, versus $90.24 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average ID prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the ID average for this medication. 33 30-Day Fills standardized to 30-day supplies 730 Days of Medication total across all patients in 2023 | |||
| Boostrix TdapDiphth,pertuss(Acell),tet Vac | 13 | $68.58 | ▼ Less than typical |
In 2023, this provider wrote 13 Medicare prescriptions for Boostrix Tdap, about half the volume of the typical Idaho prescriber of this medication (22). Medicare paid an average of $68.58 per fill, versus $64.03 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average ID prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 13 30-Day Fills standardized to 30-day supplies 13 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. DAVID QUINN YOUNGBLOOD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pharmacist prescribing approach at this Weiser, ID practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among ID prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
